ICL Israel Financials
ICL Stock | USD 4.28 0.11 2.51% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Debt Equity Ratio | 0.84 | 0.4305 |
|
| |||||
Current Ratio | 1.22 | 1.5292 |
|
|
The financial analysis of ICL Israel is a critical element in measuring its lifeblood. Investors should not minimize ICL Israel's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Net Income |
|
ICL | Select Account or Indicator |
Understanding current and past ICL Israel Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of ICL Israel's financial statements are interrelated, with each one affecting the others. For example, an increase in ICL Israel's assets may result in an increase in income on the income statement.
ICL Israel Stock Summary
ICL Israel competes with CF Industries, Mosaic, American Vanguard, CVR Partners, and Intrepid Potash. ICL Group Ltd, together with its subsidiaries, operates as a specialty minerals and chemicals company worldwide. The company was founded in 1968 and is headquartered in Tel Aviv, Israel. Israel Chemicals operates under Agricultural Inputs classification in the United States and is traded on New York Stock Exchange. It employs 12000 people.Foreign Associate | Israel |
Specialization | Basic Materials, Agricultural Inputs |
Instrument | USA Stock View All |
Exchange | New York Stock Exchange |
ISIN | IL0002810146 |
CUSIP | M53213100 M5920A109 465036200 |
Location | Israel |
Business Address | Millenium Tower, Tel |
Sector | Chemicals |
Industry | Materials |
Benchmark | Dow Jones Industrial |
Website | www.icl-group.com |
Phone | 972 3 684 4400 |
Currency | USD - US Dollar |
ICL Israel Key Financial Ratios
Return On Equity | 0.081 | ||||
Profit Margin | 0.06 % | ||||
Operating Margin | 0.12 % | ||||
Price To Sales | 0.76 X | ||||
Revenue | 7.65 B |
ICL Israel Key Balance Sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 9.2B | 9.7B | 11.1B | 11.8B | 11.5B | 7.7B | |
Other Current Liab | 587M | 741M | 938M | 1.0B | 844.0M | 531.1M | |
Net Debt | 2.5B | 2.6B | 2.5B | 2.4B | 2.2B | 2.0B | |
Retained Earnings | 3.9B | 3.8B | 4.3B | 5.4B | 5.5B | 5.8B | |
Accounts Payable | 712M | 735M | 1.1B | 1.0B | 904.5M | 633.2M | |
Cash | 95M | 214M | 473M | 417M | 416.5M | 437.4M | |
Net Receivables | 1.2B | 1.3B | 1.8B | 1.9B | 1.6B | 1.2B | |
Good Will | 302M | 320M | 502M | 507M | 525.6M | 266.1M | |
Inventory | 1.3B | 1.3B | 1.6B | 2.1B | 1.7B | 1.3B | |
Other Current Assets | 51M | 50M | 115.2M | 4.0B | 121.0M | 114.9M | |
Total Liab | 5.1B | 5.6B | 6.3B | 6.0B | 5.5B | 4.5B | |
Total Current Assets | 2.7B | 2.8B | 3.9B | 4.5B | 4.0B | 2.9B | |
Short Term Debt | 420M | 684M | 577M | 512M | 850.9M | 537.1M | |
Intangible Assets | 332M | 336M | 365M | 345M | 343M | 403.7M | |
Other Liab | 1.2B | 1.3B | 1.3B | 1.1B | 1.3B | 1.1B | |
Other Assets | 362M | 309M | 378M | 524M | 434.7M | 384.2M | |
Long Term Debt | 2.2B | 2.1B | 2.4B | 2.3B | 1.6B | 2.3B | |
Net Tangible Assets | 3.3B | 3.3B | 3.7B | 4.6B | 5.3B | 3.1B | |
Short Long Term Debt | 371M | 684M | 577M | 512M | 786M | 523.7M | |
Long Term Debt Total | 1.8B | 2.2B | 2.1B | 2.4B | 2.2B | 1.9B |
ICL Israel Key Income Statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Interest Expense | 220M | 219M | 216M | 327M | 176.7M | 120.4M | |
Total Revenue | 5.3B | 5.0B | 7.0B | 10.0B | 7.7B | 5.7B | |
Gross Profit | 1.8B | 1.5B | 2.6B | 5.0B | 2.6B | 2.2B | |
Operating Income | 756M | 202M | 1.2B | 3.5B | 1.2B | 1.1B | |
Ebit | 1.3B | 144.3M | 1.3B | 3.7B | 1.2B | 1.2B | |
Research Development | 50M | 54M | 64M | 68M | 72.1M | 61.5M | |
Ebitda | 1.3B | 757M | 1.8B | 4.2B | 1.8B | 1.4B | |
Cost Of Revenue | 3.5B | 3.6B | 4.3B | 5.0B | 5.1B | 3.5B | |
Income Before Tax | 628M | 49M | 1.1B | 3.4B | 988.3M | 968.8M | |
Net Income | 475M | 24M | 783M | 2.2B | 647M | 751.3M | |
Income Tax Expense | 147M | 25M | 260M | 1.2B | 291.5M | 217.3M | |
Minority Interest | 136M | 158M | (49M) | (60M) | (34M) | (32.3M) | |
Tax Provision | 147M | 25M | 260M | 1.2B | 412M | 309.6M | |
Interest Income | 89M | 61M | 94M | 214M | 39M | 37.1M | |
Net Interest Income | (106M) | (140M) | (158M) | (122M) | (113M) | (147M) |
ICL Israel Key Cash Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change To Inventory | (72M) | 54M | (267M) | (527M) | 472.3M | 495.9M | |
Change In Cash | (26M) | 119M | 259M | (56M) | (1.6M) | (1.5M) | |
Free Cash Flow | 416M | 178M | 454M | 1.3B | 827.8M | 530.5M | |
Depreciation | 443M | 489M | 490M | 498M | 590.1M | 349.0M | |
Other Non Cash Items | 130M | 1M | (21M) | (1.2B) | 414.4M | 435.1M | |
Dividends Paid | 273M | 118M | 276M | 1.2B | (489M) | (464.6M) | |
Capital Expenditures | 576M | 626M | 611M | 747M | 792.3M | 507.7M | |
Net Income | 481M | 24M | 832M | 2.2B | 657.2M | 754.5M | |
End Period Cash Flow | 95M | 214M | 473M | 417M | 416.5M | 437.4M | |
Investments | (525M) | (583M) | (579M) | (754M) | (805M) | (764.8M) | |
Net Borrowings | (215M) | (10M) | 52M | (157M) | (141.3M) | (134.2M) | |
Change To Netincome | (4M) | 196M | 95M | 91M | 104.7M | 109.9M |
ICL Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining ICL Israel's current stock value. Our valuation model uses many indicators to compare ICL Israel value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ICL Israel competition to find correlations between indicators driving ICL Israel's intrinsic value. More Info.ICL Israel Chemicals is rated fifth overall in return on equity category among its peers. It is rated fourth overall in return on asset category among its peers reporting about 0.53 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for ICL Israel Chemicals is roughly 1.90 . At this time, ICL Israel's Return On Equity is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value ICL Israel by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.ICL Israel Chemicals Systematic Risk
ICL Israel's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. ICL Israel volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was five with a total number of output elements of fifty-six. The Beta measures systematic risk based on how returns on ICL Israel Chemicals correlated with the market. If Beta is less than 0 ICL Israel generally moves in the opposite direction as compared to the market. If ICL Israel Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one ICL Israel Chemicals is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of ICL Israel is generally in the same direction as the market. If Beta > 1 ICL Israel moves generally in the same direction as, but more than the movement of the benchmark.
ICL Israel Thematic Clasifications
ICL Israel Chemicals is part of Chemicals investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Chemicals industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
This theme covers USA Equities from Chemicals industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas
Chemicals | View |
Today, most investors in ICL Israel Stock are looking for potential investment opportunities by analyzing not only static indicators but also various ICL Israel's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of ICL Israel growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
ICL Israel November 12, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of ICL Israel help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of ICL Israel Chemicals. We use our internally-developed statistical techniques to arrive at the intrinsic value of ICL Israel Chemicals based on widely used predictive technical indicators. In general, we focus on analyzing ICL Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build ICL Israel's daily price indicators and compare them against related drivers.
Downside Deviation | 2.25 | |||
Information Ratio | 0.0063 | |||
Maximum Drawdown | 12.57 | |||
Value At Risk | (3.37) | |||
Potential Upside | 5.13 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ICL Israel Chemicals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Fertilizers & Agricultural Chemicals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ICL Israel. If investors know ICL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ICL Israel listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.29) | Dividend Share 0.201 | Earnings Share 0.33 | Revenue Per Share 5.458 | Quarterly Revenue Growth (0.06) |
The market value of ICL Israel Chemicals is measured differently than its book value, which is the value of ICL that is recorded on the company's balance sheet. Investors also form their own opinion of ICL Israel's value that differs from its market value or its book value, called intrinsic value, which is ICL Israel's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ICL Israel's market value can be influenced by many factors that don't directly affect ICL Israel's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ICL Israel's value and its price as these two are different measures arrived at by different means. Investors typically determine if ICL Israel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ICL Israel's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.